cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Lava Therapeutics Nv
4 own
3 watching
Current Price
$2.6
$0.7
(36.84%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
68.35M
52-Week High
52-Week High
7.38
52-Week Low
52-Week Low
1.365
Average Volume
Average Volume
32.79M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization68.35M
icon52-Week High7.38
icon52-Week Low1.365
iconAverage Volume32.79M
iconDividend Yield--
iconP/E Ratio--
What does the Lava Therapeutics Nv do?
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for blood cancers, including chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia; and LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is also developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 and LAVA-1278, which are preclinical candidates for the treatment of various hematologic malignancies. LAVA Therapeutics N.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use. The company was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.
Read More
News & Events about Lava Therapeutics Nv.
Globe Newswire
2 months ago
UTRECHT, The Netherlands and PHILADELPHIA, March 09, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody platform of bispecific gamma-delta T cell engagers, today announced the appointment of Christy...
Globe Newswire
3 months ago
UTRECT, The Netherlands and PHILADELPHIA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq LVTX), an immuno-oncology company focused on developing its proprietary Gammabody platform of bispecific gamma-delta T cell engagers to transform the treatment of cancer, today announced that ...
Globe Newswire
4 months ago
UTRECHT, The Netherlands and PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), an immuno-oncology company focused on developing its proprietary Gammabody platform of bispecific gamma-delta T cell engagers to transform the treatment of cancer, today announced that...
Globe Newswire
5 months ago
Peter A. Kiener, DPhil and Mary E. Wadlinger to Join LAVA BoardUTRECHT, The Netherlands and PHILADELPHIA, Jan. 06, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody platform of bispecific gamma ...
Globe Newswire
5 months ago
UTRECHT, The Netherlands and PHILADELPHIA, Jan. 03, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical stage immuno-oncology company focused on developing its proprietary Gammabody platform of bispecific gamma-delta T cell engagers to transform the treatment of cancer, today ...
Frequently Asked Questions
Frequently Asked Questions
What is Lava Therapeutics Nv share price today?
plus_minus_icon
Can Indians buy Lava Therapeutics Nv shares?
plus_minus_icon
How can I buy Lava Therapeutics Nv shares from India?
plus_minus_icon
Can Fractional shares of Lava Therapeutics Nv be purchased?
plus_minus_icon
What are the documents required to start investing in Lava Therapeutics Nv stocks?
plus_minus_icon
What is today’s traded volume of Lava Therapeutics Nv?
plus_minus_icon
What is today’s market capitalisation of Lava Therapeutics Nv?
plus_minus_icon
What is the 52-Week High and Low Range of Lava Therapeutics Nv?
plus_minus_icon
What percentage is Lava Therapeutics Nv down from its 52-Week High?
plus_minus_icon
What percentage is Lava Therapeutics Nv up from its 52-Week Low?
plus_minus_icon
Current Price
$2.6
$0.7
(36.84%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00